Advertisement

Topics

Avista Doubles API Manufacturing Capacity At Colorado Facility

04:55 EST 15 Nov 2017 | Pharmaceutical Processing

During this expansion, the site’s three existing GMP drug substance manufacturing suites were upgraded, and a fourth GMP suite was added. The facility’s non-GMP capacity also was doubled.
Contributed Author: 
Avista Pharma Solutions

Original Article: Avista Doubles API Manufacturing Capacity At Colorado Facility

NEXT ARTICLE

More From BioPortfolio on "Avista Doubles API Manufacturing Capacity At Colorado Facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...